chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Experienced nausea, weakness and dizziness night of flu shot. No egg allergy. Many flu shots before.
1st dose of Moderna Covid 19 vaccine; nausea; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (1st dose of Moderna COVID 19 vaccine) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (1st dose of Moderna Covid 19 vaccine) and NAUSEA (nausea). At the time of the report, MYALGIA (1st dose of Moderna Covid 19 vaccine) outcome was unknown and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
44 hours after the injection, I started my period 8 days early. I normally have very regular cycles.   24 hours after injection I experienced muscle aches, mild fever and fatigue.
Influenza vaccine left medial head deltoid - within 20 minutes fullness tingling - no pain - no numbness - paresis - paralysis medial head left deltoid and long head left biceps.
Sore arm; Bad cold; Sickness; covid 19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid 19), PAIN IN EXTREMITY (Sore arm), NASOPHARYNGITIS (Bad cold) and ILLNESS (Sickness) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A, 00787721, 011F21A and 006M21A) for COVID-19 prophylaxis.     The patient's past medical history included Heart disorder. Concurrent medical conditions included Thyroid disorder.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Aug-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2022, the patient experienced COVID-19 (covid 19). In December 2022, the patient experienced ILLNESS (Sickness). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and NASOPHARYNGITIS (Bad cold). At the time of the report, COVID-19 (covid 19), PAIN IN EXTREMITY (Sore arm), NASOPHARYNGITIS (Bad cold) and ILLNESS (Sickness) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details not reported by the reporter. It was unknown that patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was reported that the patient only had a sore arm each time he had received the shot. The reporter did not know which arm he received the vaccine in and how long his sore arm lasted for. However, he never tested himself for COVID so the reporter  was unsure if had COVID again at that time.  Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-733911 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2023: Live followup received contains updated batch no and administration date.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-733911:Bivalent case
Vacc given 3/21. Site became achy next day, tender to touch, 3/22. Requiring ibuprofen for pain q 6 hours 3/23, radiated to shoulder & scapula (L). Cont to med ibuprofen Q 6 hours for pain until 3/25. Noted bruise at site 3/28. Site has been swollen since 3/22, but now decreased significantly 3/30. Seen by MD 3/28.
Did not receive 2nd dose due to Covid locked down; This case was reported by a consumer via interactive digital media and described the occurrence of social problem in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on January 2020).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.   Additional Information: GSK Receipt Date: 12-SEP-2022 Reporter's Comments: This case was received from consumer via interactive digital media. The reporter husband had the first dose of Shingrix. When the patient was due for the second does, everything was locked down due to Covid.  The patient never got the second dose.  No one seems to be able to tell us if he should now get the vaccine. The follow-up could not be possible as no contact details were available.
patient experienced some bad reactions; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (patient experienced some bad reactions) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (patient experienced some bad reactions). At the time of the report, IMMUNISATION REACTION (patient experienced some bad reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.   Reporter did not allow further contact
feels lightheaded; fever; chills; headache; stomach upset; could not eat; diarrhea; aches all over; weak; This is spontaneous report from contactable consumer. This consumer (patient) reported that a 78-years-old female patient received first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, batch/lot Number: EW0170), (at the age of 78-years-old) via an unspecified route of administration on 28Apr2021 at 15:00 (Wednesday afternoon) on right arm as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient stated that after received shot she had been sick ever since. She has been taking two Tylenol every six hours. On 28Apr2021, the patient feels lightheaded when she gets up, fever and chills at night, headache, stomach upset, could not eat up until today and stated that she ate jello, diarrhea, stated that she did not known if she can drive or not that she was weak, aches all over and that the other day when she had the headache that Tylenol would not take it away. Stated that she was okay when she got it and it took 4 hours to get sick. Stated that she could not even drive. Stated that she had Covid on 28Jan2021 and waited 90 days to get the shot. The patient treated herself by using cold packs. The outcome of adverse events feels lightheaded, stomach upset, diarrhea, weak and aches all over was not recovered. On 29Apr2021, fever, chills were recovered. On 30Apr2021, headache was recovered. The outcome of adverse event could not eat was unknown.    No follow-up attempts are needed. No further information is expected.
7W & 4D pregnant at the time of this vaccination, No complications with pregnancy.  Fever, chills, body aches, migraine, nausea, vomiting, hot & cold flashes for 2 days. Symptoms started 12 hrs after vaccine received.
INR was too high; Missed dose; She's so weak; No appetite; Fever; Got sick; felt tired and very sick; Weak and tired; This spontaneous case was reported by a consumer and describes the occurrence of INTERNATIONAL NORMALISED RATIO INCREASED (INR was too high) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included WARFARIN SODIUM (COUMADIN) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2001, the patient experienced FATIGUE (Weak and tired). On 14-Feb-2012, the patient experienced ILLNESS (Got sick; felt tired and very sick). On an unknown date, the patient experienced INTERNATIONAL NORMALISED RATIO INCREASED (INR was too high) (seriousness criterion hospitalization prolonged), ASTHENIA (She's so weak), DECREASED APPETITE (No appetite), PYREXIA (Fever) and PRODUCT DOSE OMISSION ISSUE (Missed dose). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, INTERNATIONAL NORMALISED RATIO INCREASED (INR was too high), ILLNESS (Got sick; felt tired and very sick), ASTHENIA (She's so weak), DECREASED APPETITE (No appetite), PYREXIA (Fever), FATIGUE (Weak and tired) and PRODUCT DOSE OMISSION ISSUE (Missed dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include, Komento 2mg. No additional treatment information was reported.  The patient was hospitalized 2 weeks after receiving the first dose of Moderna vaccine due to increased INR. She was in the hospital for two months. She reported wanting to take the second dose, but her physician is not sure if she should.   This is a 68-year-old female patient with a serious event of international normalized ratio increased and other non-serious cases. A very limited information regarding this event (INR was too high) has been provided at this time. Based on the current available information and temporal association between the use of the product and the start date of other non-serious event, a causal relationship cannot be excluded. However, hospital discharge summary is required for further assessment.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: New event added (seriousness criterion of hospitalization), event outcome updated.; Sender's Comments: This is a 68-year-old female patient with a serious event of international normalized ratio increased and other non-serious cases. A very limited information regarding this event (INR was too high) has been provided at this time. Based on the current available information and temporal association between the use of the product and the start date of other non-serious event, a causal relationship cannot be excluded. However, hospital discharge summary is required for further assessment.
Tinnitus (humming, vibrating sound - intermittent, never had Tinnitus before)
Six to Seven days of moderate to severe body aches: back shoulders hips with heavy fatigue; loss of appetite and total exhaustion inhibiting ability to perform ADLs (generally very high functioning). Ibuprofen for several days and in bed for nearly a week and after that time symptoms improved. delayed response. only sore arm until about 72 hours. now, 14 days later near resolution of all symptoms.
Day after vaccination developed increasing anxiety and panic attacks. About 5 days post vaccine developed worsening anxiety and new onset aggressive behaviors, primarily towards parents.
patient accidentally received 0.5ml Bivalent booster instead of first primary dose; no adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of NO ADVERSE EVENT (no adverse event) and WRONG PRODUCT ADMINISTERED (patient accidentally received 0.5ml Bivalent booster instead of first primary dose) in a 31-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 059F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 07-Dec-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 07-Dec-2022, the patient experienced NO ADVERSE EVENT (no adverse event). On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (patient accidentally received 0.5ml Bivalent booster instead of first primary dose). At the time of the report, NO ADVERSE EVENT (no adverse event) had not resolved and WRONG PRODUCT ADMINISTERED (patient accidentally received 0.5ml Bivalent booster instead of first primary dose) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (patient accidentally received 0.5ml Bivalent booster instead of first primary dose).    Moderna is authorized to communicate with the vaccine recipient's primary healthcare professional regarding this notification No Concomitant Medication was provided by reporter. No Treatment Medication was provided by reporter.
Night chills. I woke in the middle of the night shivering. I covered my head with my blanket and returned to sleep. This occurred the night of following all 3 doses and the second night following the first 2
Patient presents to the emergency department for worsening diarrhea. He was subsequently admitted for C- Diff infection. Patient was discharged 2 days later to home in stable condition.
I experienced a large area of redness, swelling, itching, and it kept getting better which ran down my left arm to my elbow. I ended up going to the after hours urgent care at Clinic where I was seen by a PA who said that if it became worse to let them know and was given a prescription for asteroid and a cream to relieve the symptoms.
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, intramuscular, batch number: 203A21A, expiry: 21-SEP-2021) dose was not reported, administered on 22-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 22-SEP-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine  was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20210943966 and 20210943969.
Information has been received from a physician concerning a 26 year old pregnant female with no known allergies and no past medical history who on 06/29/2001 was vaccinated with the first dose of MMR II. The pt was vaccinated 1 1/2 weeks prior to (LMP: 06/19/2001). The pt sought unspecified medical attention. The pregnancy was confirmed by a urine and beta hCG. During her pregnancy, it was reported that the pt had a urinary tract infection and was prescribed Macrobid from her primary care. It was also noted that the pt was taking prenatal vitamins. The pt had an ultrasound, 6 weeks from LMP, with "no fetal pole or cardiac activity." At 9 weeks from LMP, the pt had a spontaneous abortion, requiring dilatation and curetage. It was also noted that the pt had one previous pregnancy which did not result in a live birth. It was reported to be uncertain if a birth defect had occurred. Additional info has been requested.
Patient has had approx. 35% hair loss since hair loss started in early/mid September, 2002.  She was administered the Hepatitis B vaccine, starting on April 29th of 2002, received the second shot on June 3, 2002 and the final shot on October 4th 2002. Her hair continues to fall out at a rate of at least 200 hairs per day, despite therapy with Rogaine (for past 3 weeks).  Telogen effluvium.  Immediately following the last shot, she felt exhausted as if she had come down with "mono."  She also received the flu vaccine on 10/4/02.  Some fatigue has continued.  She also has an aggravation of asthma and upper respiratory symptoms.  Please contact Healthcare providers for Vaccine Maker and lot#s.
Nausea and vomiting. Started about 14 hours after vaccine. Lasted about 8 hours. Fatigue the following day but not sure if secondary to promethazine or being up all night.  Maximum temp was 99.4 orally
Spoke to patient. TDaP was given right upper arm on 5/31/15. Arm became sore that night. Redness "just noticed yesterday." "3 pea sized nodules" two above elbow, one facing the axillary (none at the injection site). Associated pain and the one on the axillary side of arm looks "bruised." Nodules appeared 3 days ago.  Also complained about a lump on left breast, concern over whether this is associated vs a clogged milk duct.
Lymphoma; anaphylaxis; crazy; going to kill somebody; just do not feel well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANAPHYLACTIC REACTION (medically significant), outcome "not recovered", described as "anaphylaxis"; LYMPHOMA (medically significant), outcome "not recovered"; MALAISE (non-serious), outcome "unknown", described as "just do not feel well"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "crazy"; AGGRESSION (non-serious), outcome "unknown", described as "going to kill somebody". The events "anaphylaxis" and "lymphoma" required physician office visit. Clinical course: After vaccination for COVID-19, patient had anaphylaxis and still was going troubling with the side effect after the vaccination and was diagnosed by allergist after that with Lymphoma. The patient just did not feel well, patient was crazy. The patient was going to kill somebody.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Initial report was received from a health care professional, who was also the patient, on 16 July 2012. A 34-year-old female patient had received an injection of MENACTRA (lot number, route and site not reported) in January of 2012. On 10 July 2012, the patient developed back pain, ascending paresthesias and numbness in both legs, saddle area, right hand and arm. The patient was seen in the emergency room (ER) and had an MRI on 10 July 2012 that revealed herniation of S1 without nerve involvement. The patient was started on MEDROL dose pack that was discontinued after two days. The patient was seen again in the ER on 16 July 2012 with no change to symptoms and was to see a neurologist. Past medical history and concomitant medications were unknown. The patient's outcome was not recovered. Documents held by sender: None.
Blurred vision started on day 2 after receiving the 2nd dose. My vision is so blurred I don't even know if I'm spelling this right.... and I wear prescription frames.
This case was reported by a physician and described the occurrence of injection site induration in a male subject of unspecified age who was vaccinated with BOOSTRIX (GlaxoSmithKline). There were no concurrent medications. On 14 May 2011 the subject received unspecified dose of BOOSTRIX (unknown). On the same day of BOOSTRIX administration, 14 May 2011, the subject experienced a local reaction with symptoms of injection site induration, injection site tenderness and injection site redness. The subject was seen on 20 May 2011 and was still complaining of local reaction. At the time of reporting the outcome of the events was unspecified. The physician considered the events were possibly related to vaccination with BOOSTRIX. Follow-up information received via the physician on 06 July 2011 indicated that the subject was a 39 year old male. BOOSTRIX was administered at 0.5 ml in the right deltoid on 14 May 2011. On the same day, 14 May 2011, following vaccination with BOOSTRIX, the subject experienced a local reaction with injection site induration, injection site tenderness and injection site redness. The events resolved with sequelae by 20 May 2011. In the reporter's opinion, the events were possibly related to treatment with TWINRIX. Medical history included high cholesterol and GERD.
First two days just a headache and body aches. By third night into 4th severe neck pain into shoulder blade and down into arm. Pain in arm pit as well.
Malaise, Fever, Chills, Muscle Pain, Fatigue, Headache, Injection Site Pain
Pain in the left shoulder going to elbow; Fatigue; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the left shoulder going to elbow), FATIGUE (Fatigue), NAUSEA (Nausea) and HEADACHE (Headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in the left shoulder going to elbow), FATIGUE (Fatigue), NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Pain in the left shoulder going to elbow), FATIGUE (Fatigue), NAUSEA (Nausea) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Site: Bruising at Injection Site-Severe, Site: Swelling at Injection Site-Mild
I felt OK after vaccine but by the 2nd day in the afternoon I started feeling sick, weak, fatigued, and when I laid down in bed I felt like I had covid again. I couldn't move, use bathroom, couldn't move at all. That's the same way I felt with covid. The next morning, I could move a little bit but not much and I felt a lot better. I didn't feel like I had covid anymore and then the next day I felt back to normal.
She began having shortness of breath after getting her second shot. He parents found her dead in her bed this afternoon. No other known comorbidities.